Close Menu

NEW YORK (GenomeWeb) – Singulex said today that it has received the CE mark in Europe for its Sgx Clarity system. The Alameda, California-based immunodiagnostics firm will now start marketing its single-molecule counting instrument as an in vitro diagnostics system.

Singulex also plans to pursue the CE mark for its cardiac troponin I assay and plans to submit data to the US Food and Drug Administration for clearance in 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jun
19

This webinar will discuss cell-free DNA prenatal screening in the era of genome-wide sequencing and factors influencing the clinical utility of expanded noninvasive prenatal testing (NIPT) menus.

Jul
23
Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.